Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Update on US review of Fasenra in nasal polyps
Investegate announcements from AstraZeneca PLC, Update on US review of Fasenra in nasal polyps
Source: investegate.co.uk
Page 2 - Frequent Exacerbations News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Frequent Exacerbations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Frequent Exacerbations Today - Breaking & Trending Today
First patients dosed in Phase III trials evaluating Fasenra in hypereosinophilic syndrome, eosinophilic esophagitis and eosinophilic granulomatosis
Search jobs 16-Dec-2020 First patients dosed in Phase III trials evaluating Fasenra in hypereosinophilic syndrome, eosinophilic esophagitis and eosinophilic granulomatosis with polyangiitis New clinical trial also announced for Fasenra in eosinophilic gastritis/eosinophilic gastroenteritis The first patients have been dosed in Fasenra (benralizumab) Phase III trials in three rare eosinophilic diseases: hypereosinophilic syndrome (HES), eosinophilic esophagitis (EoE) and eosinophilic granulomatosis with polyangiitis (EGPA) AstraZeneca will al...
Source: pharmiweb.com